<html>
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
   <link rel="stylesheet" type="text/css" href="html_style_eog.txt"/>
<script type="text/javascript">
		function printpage()
		{
		window.print()
		}
		</script></head>
   <body bgcolor='#FFFFFF' onload='javascript: if ((navigator.appName.indexOf("Netscape")!=-1) && parent.leftFrame!=null) parent.leftFrame.location.reload();'><basefont face="Times New Roman, Times New Roman, Times New Roman " size="2">
         <div style="margin-left: +10pt">
            <table width="90%" border="0" rules="none" align="center">
               <colgroup>
                  <col width="90%">
               </colgroup>
               <tr align="center">
                  <td width="20%" colspan="1" rowspan="2" align="left" valign="top">
                     <form><input name="button" type="button" value="   Full Text   " onClick="javascript:document.location.href=('http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=7473525');"></form>
                  </td>
                  <td class="table_data"><b>US 7,473,525 B2</b></td>
                  <td width="20%" colspan="1" rowspan="2" align="right" valign="top">
                     <form><input type="button" value="Print this page" onclick="printpage()"></form>
                  </td>
               </tr>
               <tr align="center">
                  <td colspan="1" class="table_data" style="text-transform: uppercase"><b>Compositions and methods for inhibiting expression of anti-apoptotic genes</b></td>
               </tr>
               <tr align="center">
                  <td colspan="3" class="table_data"><b> Roland Kreutzer,  Weidenberg (Germany);  Stefan Limmer,  Neudrossenfeld (Germany);  Hans-Peter Vornlocher,  Bayreuth (Germany);  Philipp Hadwiger,  Bayreuth (Germany);  Anke Geick,  Bayreuth (Germany);  Matthias Ocker,  Erlangen (Germany);  Christoph Herold,  Erlangen (Germany); and  Detlef Schuppan,  Bubenreuth (Germany)</b></td>
               </tr>
               <tr align="center">
                  <td colspan="3" class="table_data"><b>Assigned to  Alnylam Europe AG,  Cambridge, Mass. (US)</b></td>
               </tr>
               <tr align="center">
                  <td colspan="3" class="table_data"><b>Filed on Mar.  07, 2003, as Appl. No. 10/384,260.</b></td>
               </tr>
               <tr>
                  <td colspan="3" class="table_data" align="center"><b>Application 10/384260 is a continuation in part of application No. PCT/EP02/00151, filed on Jan.  09, 2002.</b></td>
               </tr>
               <tr align="center">
                  <td colspan="3" class="table_data"><b>Claims priority of application No. 101 00 586 (DE), filed on Jan.  09, 2001.</b></td>
               </tr>
               <tr align="center">
                  <td colspan="3" class="table_data"><b>Prior Publication US 2004/0001811 A1, Jan.  01, 2004</b></td>
               </tr>
               <tr align="center">
                  <td colspan="3" class="table_data"><b>Int. Cl. </b><i><b>C12Q 1/68</b></i> (2006.01); <i><b>C12P 19/34</b></i> (2006.01); <i><b>C12N 5/00</b></i> (2006.01); <i><b>C12N 5/02</b></i> (2006.01); <i><b>C07H 21/02</b></i> (2006.01); <i><b>C07H 21/04</b></i> (2006.01)
                  </td>
               </tr>
            </table>
            <table width="90%" border="0" rules="none" align="center">
               <colgroup>
                  <col width="75%">
                  <col width="15%">
               </colgroup>
               <tr align="left">
                  <td class="table_data" align="left"><b>U.S. Cl. </b><b>435&#8212;6</b>&nbsp;&nbsp;[435/91.1; 435/325; 435/375; 536/23.1; 536/24.3; 536/24.33; 536/24.5]
                  </td>
                  <td class="table_data" align="right"><b>4 Claims</b></td>
               </tr>
            </table>
            <center><img src="US07473525-20090106-D00000.gif" alt="OG exemplary drawing"></center>
            <table width="90%" border="0" rules="none" align="center">
               <colgroup>
                  <col width="90%">
               </colgroup>
               <tr>
                  <td class="table_data" align="center">&nbsp;</td>
               </tr>
               <tr>
                  <td valign="top" class="para_text">1. A method for inhibiting the expression of an anti-apoptotic gene in a cell, the method comprising: (a) introducing into
                     the cell in vitro a double-stranded ribonucleic acid (dsRNA), wherein the dsRNA consists of less than 25 nucleotides in length
                     and comprises a complementary RNA strand comprising a complementary nucleotide sequence which is complementary to at least
                     a part of the Bcl-2 gene, and wherein the complementary nucleotide sequence consists of at least 24 nucleotides in length
                     and comprises SEQ ID NO:2; and (b) maintaining the cell produced in step (a) for a time sufficient to obtain degradation of
                     the mRNA transcript of the anti-apoptotic gene, thereby inhibiting expression of the Bcl-2 gene in the cell.
                  </td>
               </tr>
            </table>
         </div></body>
</html>
